14 completed, 4 unknown, 1 recruiting, 1 terminated. 21 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 21 | Completed 14, Unknown 4, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life Apollo Neuro Device, Sham device - Systemic Sclerosis (SSc) | Not applicable | Recruiting | Robyn T. Domsic, MD, MPH | 160 | 2025-01-06 | 2026-01-08 |
| Phototherapy For Treatment Of Raynaud's Phenomenon Blue Light Therapy, Sham Light Therapy - Raynaud Disease, Raynaud Phenomenon | Not applicable | Withdrawn | University of Minnesota | 2022-08-01 | 2023-01-06 | |
| Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis Rheopheresis treatment, Intravenous Infusion - Systemic Sclerosis, Raynaud Phenomenon | Not applicable | Unknown | Peter Korsten | 30 | 2022-02-28 | 2022-03-23 |
| Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon L-citrulline, Beetroot juice, L-citrulline placebo - Raynaud Phenomenon | Not applicable | Unknown | University Hospital, Grenoble | 30 | 2020-10-01 | 2021-05-14 |
| Apollo Device for Fatigue in Systemic Sclerosis Apollo - Systemic Sclerosis, Fatigue | Not applicable | Completed | Robyn T. Domsic, MD, MPH | 25 | 2020-07-07 | 2025-04-02 |
| Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. gammaCore Sapphire, Sham Device - Raynaud Phenomenon, Primary Raynaud Phenomenon | Not applicable | Terminated | University of Toledo Health Science Campus | 6 | 2019-04-30 | 2025-07-15 |
| Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon Electrotherapy with Galvanic Current, Control without Electric Stimulation Therapy - Raynaud Phenomenon, Raynaud Disease | Not applicable | Completed | Universidad de Granada | 60 | 2018-10-01 | 2020-11-09 |
| Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon Concentrated beetroot juice - Raynaud Phenomenon | Not applicable | Completed | University of Portsmouth | 27 | 2017-07-01 | 2020-02-10 |
| Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon Examination of vibration perception threshold in fingertips, Ewing's tests, Tilt table test - Raynaud Disease, Raynaud Phenomenon | Not applicable | Completed | Herlev Hospital | 174 | 2017-01-01 | 2019-02-28 |
| Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon. Biopsy - Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary) | Not applicable | Completed | University Hospital, Grenoble | 29 | 2016-10-18 | 2020-04-09 |
| The Effects of Exercise in Patients With Systemic Sclerosis Exercise intervention - Cycling, Exercise intervention - arm cranking - Systemic Sclerosis, Raynaud's Phenomenon | Not applicable | Completed | Sheffield Hallam University | 36 | 2016-06-01 | 2019-04-08 |
| Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon placebo, diosmiplex - Raynaud's Disease | Not applicable | Completed | Primus Pharmaceuticals | 87 | 2016-02-01 | 2017-08-17 |
| A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) Manual blood pressure cuff inflation over brachial artery - Raynaud Disease, Raynaud's Phenomenon | Not applicable | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 21 | 2015-07-01 | 2018-08-08 |
| Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) Celution Device, Placebo - Scleroderma, Systemic Sclerosis | Not applicable | Completed | Cytori Therapeutics | 88 | 2015-05-15 | 2018-06-04 |
| Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon Demonstration of genetic mutations causing Raynaud's phenomenon - Primary Raynaud's Phenomenon (PR), Genetic Mutations Causing PR | Not applicable | Completed | Nantes University Hospital | 258 | 2014-10-13 | 2020-06-24 |
| PORH and Response to Cold in Raynaud's Phenomenon. post-occlusive hyperemia, cooling box, L-NMMA and Fluconazole dermic injection - Raynaud Disease, Hyperemia | Not applicable | Unknown | University Hospital, Grenoble | 60 | 2014-06-01 | 2015-12-09 |
| Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. laser speckle contrast imaging, Cooling - Raynaud Disease, Scleroderma, Systemic | Not applicable | Completed | University Hospital, Grenoble | 101 | 2012-01-01 | 2016-06-02 |
| Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands Tracleer, Prostavasin - Raynaud's Phenomenon, Skin Necrosis | Not applicable | Unknown | Christoph Hehrlein | 30 | 2011-07-01 | 2014-12-15 |
| Botulinum Toxin in the Treatment of Raynaud's botulinum toxin A - Raynaud's Syndrome | Not applicable | Completed | Emory University | 10 | 2010-10-01 | 2014-04-21 |
| Tadalafil for the Treatment of Raynaud's Tadalafil - Raynaud | Not applicable | Completed | Northwestern University | 10 | 2008-09-01 | 2014-12-04 |
Showing 20 of 21. Sign in to see all of them.
Raynaud Disease (21) · Scleroderma, Systemic (7) · Scleroderma, Diffuse (4) · Fatigue (2) · Pain (2) · Common Cold (1) · Diabetes Mellitus (1) · Glaucoma (1) · Hand-Arm Vibration Syndrome (1) · Hyperemia (1) · Motor Activity (1) · Necrosis (1) · Parkinson Disease (1) · digital ulcers (1)
Cardiovascular Diseases (21) · Embolism and Thrombosis (21) · Peripheral Vascular Diseases (21) · Skin Diseases (21) · Skin Diseases, Vascular (21) · Skin and Connective Tissue Diseases (21) · Thrombosis (21) · Vascular Diseases (21) · Connective Tissue Diseases (8) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Neurologic Manifestations (2) · Basal Ganglia Diseases (1) · Behavior (1)
Alprostadil (1) · Biofeedback, Psychology (1) · Biopsy (1) · Blood Specimen Collection (1) · Bosentan (1) · Botulinum Toxins, Type A (1) · Citrulline (1) · Control Groups (1) · Cool-Down Exercise (1) · Electric Stimulation Therapy (1) · Infusions, Intravenous (1) · Laser Speckle Contrast Imaging (1) · Phototherapy (1) · Tadalafil (1) · Thermography (1)
University Hospital, Grenoble (4) · Robyn T. Domsic, MD, MPH (2) · Charite University, Berlin, Germany (1) · Christoph Hehrlein (1) · Cytori Therapeutics (1) · Emory University (1) · Herlev Hospital (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Nantes University Hospital (1) · Northwestern University (1) · Peter Korsten (1) · Primus Pharmaceuticals (1) · Sheffield Hallam University (1) · Universidad de Granada (1) · University of Minnesota (1)
United States (8) · France (5) · Germany (3) · United Kingdom (2) · Canada (1) · Denmark (1) · Spain (1)
Robyn T Domsic, MD (2) · Anne Laumann, MBChB, MRCP (1) · Bashar Kahaleh, MD (1) · Janet E Pope (1) · Jean-Luc Cracowski, MD (1) · Jean-Manuel Kubina, Dr (1) · Jerry Molitor, MD, PhD (1) · Lars T Jensen, DMSc (1) · Luc Bressollette, Prof (1) · Marc-Antoine Pistorius, Prof (1) · Mark Kerber, Dr. med. (1)
PMID 21476099, PMID 24990822, PMID 29871697, PMID 30463598, PMID 31220505, PMID 31933034, PMID 33804657, PMID 35358372, PMID 35492333, PMID 37929840, PMID 39617410, PMID 42643722